Figure 6
The change of LDH leakage rate intervened with the DP agonists and antagonists.
(a) BW245C and (d) CAY10471 significantly decreased the LDH leakage rate in Al3+-treated groups. (b) BWA868C and (c) DK-PGD2 increased the LDH leakage rate in Al3+-treated groups. Values were mean ± SD of four individual experiments (n = 4. ##P < 0.01 compared with control group. **P < 0.01 compared with Al3+-treated group, one-way ANOVA with Dunnett’s multiple comparisons).
